Ardsley Advisory Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-100,000
Closed -$9.43M 195
2019
Q1
$9.43M Buy
100,000
+50,000
+100% +$4.37M 1.81% 22
2018
Q4
$3.21M Buy
+50,000
New +$3.69M 0.81% 32
2018
Q2
Sell
-200,000
Closed -$17.8M 202
2018
Q1
$17.8M Buy
+200,000
New +$19.2M 2.67% 8

Other funds holding CELG

Ardsley Advisory Partners's CELG Position: Q3 2019 in Review

Ardsley Advisory Partners sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 19,900 shares — an estimated $1.84M sold.

Ardsley Advisory Partners first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $26.8M in Q1 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Ardsley Advisory Partners reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Ardsley Advisory Partners sold 19,900 Celgene Corp shares in Q3 2019, an estimated $1.84M.
  • Ardsley Advisory Partners first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • Ardsley Advisory Partners's Celgene Corp position peaked at $26.8M in Q1 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Ardsley Advisory Partners's 13F filing for Q3 2019, filed 14 Nov 2019.